摘要
目的分析溶栓疗法治疗急性心肌梗死的疗效。方法选择发病在12h内的急性心肌梗死患者30例,在对症治疗的同时立即给予静脉滴注尿激酶100万U,分析患者的冠状动脉再通率情况。结果 30例患者中26例再通,再通率为86.67%,没有发生严重的不良反应。结论心肌梗死后早期采用静滴尿激酶进行溶栓安全、有效,值得临床推广应用。
Objective To investigate the thrombolytic therapy of acute myocardial infarction in patients with the clinical results.Methods The incidence of l2-hour period in 30 patients with acute myocardial infarction in the symptomatic treatment given immediately,while 100 million infusion of urokinase u,analysis of patients with coronary artery recanalization rate situation.Results 30 patients,26 patients with reperfusion,recanalization rate was 86.67%,with no serious adverse reactions.Conclusion Myocardial Infarction by Intravenous thrombolysis with urokinase for safe,effective and worthy of clinical application.
出处
《实用心脑肺血管病杂志》
2011年第7期1184-1185,共2页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词
尿激酶
静脉溶栓
冠状动脉再通
急性心肌梗死
Urokinase
Intravenous thrombolysis
Coronary reperfusion
Acute myocardial infarction
